172 related articles for article (PubMed ID: 3404974)
1. Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description.
Gattone VH; Calvet JP; Cowley BD; Evan AP; Shaver TS; Helmstadter K; Grantham JJ
Lab Invest; 1988 Aug; 59(2):231-8. PubMed ID: 3404974
[TBL] [Abstract][Full Text] [Related]
2. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
Gattone VH; MacNaughton KA; Kraybill AL
Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human polycystic and medullary cystic kidney disease with diphenylamine-induced cystic disease.
Evan AP; Gardner KD
Lab Invest; 1976 Jul; 35(1):93-101. PubMed ID: 940325
[TBL] [Abstract][Full Text] [Related]
4. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.
Gattone VH; Maser RL; Tian C; Rosenberg JM; Branden MG
Dev Genet; 1999; 24(3-4):309-18. PubMed ID: 10322639
[TBL] [Abstract][Full Text] [Related]
5. Altered mRNA expression of basement membrane components in a murine model of polycystic kidney disease.
Ebihara I; Killen PD; Laurie GW; Huang T; Yamada Y; Martin GR; Brown KS
Lab Invest; 1988 Mar; 58(3):262-9. PubMed ID: 3279260
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice.
Gattone VH; Lowden DA; Cowley BD
Dev Biol; 1995 Jun; 169(2):504-10. PubMed ID: 7781894
[TBL] [Abstract][Full Text] [Related]
7. C-fos expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57BL/6J-cpk mouse.
Rankin CA; Grantham JJ; Calvet JP
J Cell Physiol; 1992 Sep; 152(3):578-86. PubMed ID: 1506416
[TBL] [Abstract][Full Text] [Related]
8. Polyomavirus replicates in differentiating but not in proliferating tubules of adult mouse polycystic kidneys.
Atencio IA; Villarreal LP
Virology; 1994 May; 201(1):26-35. PubMed ID: 8178487
[TBL] [Abstract][Full Text] [Related]
9. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
10. [Structure and function of the experimental polycystic kidney induced by diphenylthiazole with special reference to renal micropuncture study].
Kubota K
Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):859-69. PubMed ID: 1484405
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of polycystic kidney disease.
Carone FA; Bacallao R; Kanwar YS
Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
13. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations.
Nguyen HQ; Danilenko DM; Bucay N; DeRose ML; Van GY; Thomason A; Simonet WS
Oncogene; 1996 May; 12(10):2109-19. PubMed ID: 8668336
[TBL] [Abstract][Full Text] [Related]
14. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.
Saadi-Kheddouci S; Berrebi D; Romagnolo B; Cluzeaud F; Peuchmaur M; Kahn A; Vandewalle A; Perret C
Oncogene; 2001 Sep; 20(42):5972-81. PubMed ID: 11593404
[TBL] [Abstract][Full Text] [Related]
15. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.
Ostrom L; Tang MJ; Gruss P; Dressler GR
Dev Biol; 2000 Mar; 219(2):250-8. PubMed ID: 10694420
[TBL] [Abstract][Full Text] [Related]
16. Development of multiorgan pathology in the wpk rat model of polycystic kidney disease.
Gattone VH; Tourkow BA; Trambaugh CM; Yu AC; Whelan S; Phillips CL; Harris PC; Peterson RG
Anat Rec A Discov Mol Cell Evol Biol; 2004 Apr; 277(2):384-95. PubMed ID: 15052665
[TBL] [Abstract][Full Text] [Related]
17. Taxol inhibits progression of congenital polycystic kidney disease.
Woo DD; Miao SY; Pelayo JC; Woolf AS
Nature; 1994 Apr; 368(6473):750-3. PubMed ID: 7908721
[TBL] [Abstract][Full Text] [Related]
18. A new murine model of autosomal recessive polycystic kidney disease.
Ozawa Y; Nauta J; Sweeney WE; Avner ED
Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):349-54. PubMed ID: 8341011
[TBL] [Abstract][Full Text] [Related]
19. Distribution and ontogenesis of tenascin in normal and cystic human fetal kidneys.
Daïkha-Dahmane F; Dommergues M; Narcy F; Lacoste M; Gubler MC
Lab Invest; 1995 Oct; 73(4):547-57. PubMed ID: 7474927
[TBL] [Abstract][Full Text] [Related]
20. A hereditary model of slowly progressive polycystic kidney disease in the mouse.
Takahashi H; Calvet JP; Dittemore-Hoover D; Yoshida K; Grantham JJ; Gattone VH
J Am Soc Nephrol; 1991 Jan; 1(7):980-9. PubMed ID: 1883968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
